Teva- Pharmaceutical Industries Ltd
NYSE: TEVA
$17.49
-$1.28 (-6.8%)
Real Time Data Delayed 15 Min.
TEVA Articles
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
Published:
Last Updated:
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday included Adamas Pharmaceuticals, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva Pharmaceutical and Under...
Published:
Last Updated:
Teva Pharmaceutical released its most recent earnings report before the markets opened on Thursday.
Published:
Last Updated:
We are in the midst of earnings season, during which most major companies will report and set a direction for the market. We have included the consensus earnings estimates from Thomson Reuters and...
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday included Amgen, Chipotle Mexican Grill, Lam Research, Netgear, Teva Pharmaceutical and Western Digital.
Published:
Last Updated:
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Teva Pharmaceuticals shares made a solid gain on Monday morning after the company announced a critical approval by the FDA.
Published:
Last Updated:
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday include Apple, Caterpillar, Costco, GW Pharmaceuticals, NXP Semiconductors, Southwest Airlines, Teva Pharmaceutical, Ulta Beauty...
Published:
Last Updated: